KAYTUS
KAYTUS, a leading IT infrastructure provider, has unveiled its latest upgrade, the K24V2 multi-node server, at ISC High Performance 2024. This server supports four dual-socket nodes within a compact 2U form factor, featuring a total of eight cutting-edge Intel/AMD processors. The K24V2 incorporates advanced cooling technologies optimized for extreme computing density, offering both cold plate liquid cooling and air cooling configurations. Notably, the liquid-cooling K24V2 cools components that account for more than 80% of the total power consumption, while the air-cooled variant supports CPU cooling with a TDP of up to 400W. With its emphasis on high performance, energy efficiency, and exceptional reliability, the K24V2 is tailored for demanding tasks such as modeling, simulation, and other performance-intensive applications.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240513994533/en/
K24V2 Multi-Node Server (Photo: Business Wire)
Achieving Four Times Computing Density and Higher Performance
The K24V2 server enables support for four dual-socket nodes within a 2U form factor, allowing for independent operations between nodes. Each node is compatible with two 5th Gen Intel® Xeon® processors or the latest 4th Gen AMD EPYC™ processors. It supports memory configurations up to 5600MT/s, and each node can accommodate various networking extensions such as InfiniBand, Omni-Path Architecture, and RoCE, meeting the networking requirements for HPC clusters.
Leading Cooling Solutions for Enhanced Performance and Efficiency
The liquid-cooled configuration of the K24V2 incorporates an integrated cold plate design that covers key components including the CPU, memory, and VR (Voltage Regulator). Components accounting for more than 80% of total power consumption are liquid cooled, offering efficient cooling while balancing investment control and power usage for heat dissipation. The cold plate supports various liquid-cooling connectors like SCG 03 and DAG 03, ensuring compatibility with different liquid-cooling cabinets used in data centers. The K24V2 is capable of supporting high-temperature inlet cooling liquids of up to 45°C, with the primary loop capable of drawing intake from a natural draft cooling tower. Furthermore, engineered to operate efficiently at an industry-leading ambient temperature of 45°C, this system significantly reduces energy consumption in data center operations.
The air-cooled version of the K24V2 maximizes heat dissipation performance through a high air intake design and a customized heat sink. This variant supports high-density deployments with CPUs of up to 400W TDP, delivering ultra-high performance and dense computing power tailored for air-cooled data centers.
Ensuring Security and Reliability, Streamlining Operations and Maintenance
Aside from delivering industry-leading performance per watt, the K24V2 is highly secure and reliable. The four nodes share titanium power supply units (PSUs), and the entire system supports N+N or 3+1 redundancy configurations. The liquid-cooled version features an integrated cold plate design and undergoes rigorous inspection processes before leaving the factory, including a nitrogen pressure test to effectively prevent leaks. Notably, the liquid-cooled version can identify leaking nodes in real-time, automatically cutting off node power to ensure the safety of equipment and data assets.
The K24V2 enhances user experience by offering convenient operation and maintenance features. The four nodes support hot-swappable maintenance and feature a "button"-style node switching on the front panel. This simplifies the connection of maintenance equipment for unified operations and maintenance, reduces work in the backend hot air duct, and improves overall user-friendliness.
To learn more about the new KAYTUS K24V2 Multi-Node Server, please visit our website.
About KAYTUS
KAYTUS is a prominent provider of IT infrastructure solutions, delivering a diverse range of innovative, open, and eco-friendly products for cloud, AI, edge computing, and other emerging applications. With a customer-centric approach, KAYTUS is agile and responsive to user needs through its adaptable business model. Discover more at KAYTUS.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240513994533/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom